Author

F. Puertolas-Balint

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 2 Assay:metagenomics· 2 Organism:Arabidopsis· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

B. O. Schroeder· 3 shared R. H. Feeney· 2 shared S. M. Holmberg· 2 shared S. Wongkuna· 2 shared A. I. Nieminen· 1 shared B. Brandl· 1 shared B. S. Sixt· 1 shared C. Oliveira dos Santos· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

B. O. Schroeder

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A history of repeated antibiotic usage leads to microbiota-dependent mucus defects

K. L. Krigul, R. H. Feeney, S. Wongkuna, O. Aasmets, S. M. Holmberg, R. Andreson, F. Puertolas-Balint, K. Pantiukh, L. Sootak, T. Org, T. Tenson, E. Org, B. O. Schroeder

This study shows that repeated antibiotic use in humans leads to microbiota changes that impair intestinal mucus function in mice.

bioRxiv · Mar 7, 2024Microbiology

The gut commensal Blautia maintains colonic mucus function under low fiber consumption through short-chain fatty acid-mediated activation of Ffar2

S. M. Holmberg, R. H. Feeney, V. Prasoodanan P.K., F. Puertolas-Balint, D. K. Singh, S. Wongkuna, L. M. Zandbergen, H. Hauner, B. Brandl, A. I. Nieminen, T. Skurk, B. O. Schroeder

This study shows that the gut bacterium Blautia helps maintain colonic mucus function under low fiber diets by producing short-chain fatty acids that activate Ffar2.

bioRxiv · Dec 10, 2023Microbiology

A multi-strategy antimicrobial discovery approach reveals new ways to combat Chlamydia

M. Ölander, D. Rea Vazquez, K. Meier, L. Mooij, J. Fredlund, F. Puertolas-Balint, E. Calpe, M. R. Diaz, K. van der Wal, B. O. Schroeder, B. S. Sixt

This paper identifies over sixty new antichlamydial compounds through a multi-strategy approach, showing potent, selective, and non-toxic activity against Chlamydia.

bioRxiv · Nov 30, 2023Microbiology

Revealing virulence potential of clinical and environmental Aspergillus fumigatus isolates using Whole-genome sequencing

F. Puertolas-Balint, J. W. Rossen, C. Oliveira dos Santos, M. A. Chlebowicz, E. Raangs, M. L. van Putten, P. J. Sola-Campoy, L. Han, M. Schmidt, S. Garcia-Cobos

This study uses whole-genome sequencing to compare virulence profiles of clinical and environmental Aspergillus fumigatus isolates, finding no significant differences in virulence potential between sources.

bioRxiv · Mar 28, 2019Microbiology